The roll-out of Covid-19 vaccines across the UK is the healthcare story at the top of the news agenda. But, as I discover in this feature for P3 pharmacy management magazine, for manufacturers of generic medicines, maintaining an uninterrupted supply of their products post-Brexit and mid-pandemic takes a huge amount of work that rarely hits the headlines.
